CMST COST Action D39
Metallo-Drug Design and Action
Descriptions are provided by the Actions directly via e-COST.
The main objective of the Action is to increase knowledge and understanding of the design and mechanisms of actions of metallo-drugs, and to use this enhanced knowledge in combination with modern genomic research to develop new classes of metallo-drugs with truly novel mechanisms of action and novel spectra of biomedical activity.
Chemistry and Molecular Sciences and Technologies COST Action D39
- Description
- Parties
- Management Committee
General Information*
Chair of the Action:
Prof. Viktor BRABEC (CZ)
Vice Chair of the Action:
Prof. Dan GIBSON (IL)
DC Rapporteurs:
Dr Darinka CHRISTOVA (BG)
Science officer of the Action:
Administrative officer of the Action:
Downloads*
Action Fact Sheet
Memorandum of Understanding
Progress Report
Download Progress Report as PDF
